Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 238, Issue 7, Pages 1407-1415Publisher
WILEY
DOI: 10.1002/jcp.31041
Keywords
cancer; exercise; glucose metabolic diseases; GPLD1; nervous system diseases
Categories
Ask authors/readers for more resources
This study reviewed the structure, functions, and localization of GPLD1 in chronic diseases, as well as exercise-mediated regulation of GPLD1, providing a theoretical support for developing GPLD1 as a new therapeutic target for chronic diseases.
Glycosylphosphatidylinositol-specific phospholipase D (GPLD1) is a specific enzyme for glycosylphosphatidylinositol (GPI) anchors, thereby exerting its biological functions by cleaving membrane-associated GPI molecules. GPLD1 is abundant in serum, with a concentration of approximately 5-10 & mu;g/mL. Previous studies have demonstrated that GPLD1 plays a crucial role in the pathogenesis of numerous chronic diseases including disorders of lipid and glucose metabolism, cancer, and neurological disorders. In the present study, we reviewed the structure, functions, and localization of GPLD1 in chronic diseases, as well as exercise-mediated regulation of GPLD1, thus providing a theoretical support to develop GPLD1 as a new therapeutic target for chronic diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available